These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency. Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508 [TBL] [Abstract][Full Text] [Related]
12. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420 [TBL] [Abstract][Full Text] [Related]
13. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055 [TBL] [Abstract][Full Text] [Related]
14. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875 [TBL] [Abstract][Full Text] [Related]
15. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice. Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744 [TBL] [Abstract][Full Text] [Related]
16. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. Mantchev GT; Cortesão CS; Rebrovich M; Cascalho M; Bram RJ J Immunol; 2007 Aug; 179(4):2282-8. PubMed ID: 17675489 [TBL] [Abstract][Full Text] [Related]
17. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival. Ou X; Xu S; Lam KP Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644 [TBL] [Abstract][Full Text] [Related]
18. Common variable immunodeficiency: two mutations are better than one. La Cava A J Clin Invest; 2013 Oct; 123(10):4142-3. PubMed ID: 24051372 [TBL] [Abstract][Full Text] [Related]
19. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection. Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307 [TBL] [Abstract][Full Text] [Related]
20. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells. Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]